NEW YORK (GenomeWeb) – Mesa Biotech today said that the US Food and Drug Administration has cleared and CLIA-waived the company's Accula RSV respiratory syncytial virus test for diagnostic use in both children and adults.
According to the San Diego-based firm, the nasal swab test combines the superior sensitivity, specificity, and information content of laboratory-based PCR tests and the simplicity, convenience, and procedural familiarity of traditional point-of-care rapid immunoassays.